How to obtain immune bovine milk to strengthen the body against COVID-19

Physiologically, milk contains biocomponents that are highly protective against infections. In light of this, the AGR-149-Infectious Diseases group at the University of Cordoba's Department of Animal Health is doing research that focuses on cow's milk as a possible source of COVID-19 control. The results have been published, partially, in the journal Frontiers in Immunology.

This is possible due to "crossed immunity", and there is already evidence of the protection it provides, explained one of the principal investigators, Mari Carmen Borge. "It has been shown that the immune cells that the vaccinated animal generates against bovine coronavirus are capable of controlling other coronaviruses as well, such as SARS-CoV-2, which causes Covid-19".

Antonio Arenas, principal investigator on the project, spoke of the similarity that exists between Bovine Coronavirus (BCoV) and SARS-CoV-2 to explain the effectiveness of this technique. "There are a number of highly conserved structures of the virus that are similar in both viruses. In fact, both belong to the genus Betacoronavirus. Thus, cow's milk could have a total or partial blocking action against SARS-CoV-2".

In this way, these bovine antibodies could neutralize the virus in people who are already infected, or help prevent the disease in those who have not been vaccinated, or who have been, but have not developed immunity.

Thus, the aim is to come up with a supplement that would boost the immune system through a dairy preparation with a high level of antibodies, helping the system control infection through different immune pathways.

The animals from which the milk is extracted have been previously vaccinated with commercial BCoV vaccines, thus generating high levels of antibodies. However, the time when milk is most effective is just after a birth: "then the level of immunoglobulin in the milk increases - what is called colostrum - but it has a certain duration," Arenas added.

Now the scientific challenge is to be able to extend the colostrum period, and also to study how to always ensure the same level of antibodies in the final product. Plans call for it to be marketed in single-dose format as of September. "For this, we have to readjust the reproduction cycles of bovine farms in order to always maintain a set of animals with high antibodies", the researcher explained.

This dairy preparation, which anyone can consume, has already been tested on more than 300 people. Amongst them, no serious Covid-19 process has been detected. As soon as it goes on the market an observational test will be carried out. In any case, it will not be harmful to health, and it could become a natural resource providing people with a certain level of immunity.

There are other technological challenges: herd management, hygiene processes, conservation, packaging, marketing, medical, etc., that make this a holistic and complex project.

Arenas A, Borge C, Carbonero A, Garcia-Bocanegra I, Cano-Terriza D, Caballero J, Arenas-Montes A.
Bovine Coronavirus Immune Milk Against COVID-19.
Front Immunol. 2021 Mar 23;12:637152. doi: 10.3389/fimmu.2021.637152.

Most Popular Now

Positive new data for Johnson & Johnson single…

Johnson & Johnson (NYSE: JNJ) (the Company) announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly sp...

GSK and Alector announce global collaboration in i…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Alector (Nasdaq: ALEC), today announced a strategic global collaboration for the development and commercialisation of two clinical...

Tezepelumab granted Priority Review by U.S. FDA

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for tezepelu...

One shot of the Sputnik V vaccine triggers strong …

A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine...

Are silver nanoparticles a silver bullet against m…

Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They can be in the form of antibiotics, used to treat bodily infections...

"Long COVID": More than a quarter of COV…

In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight mon...

mRNA vaccines slash risk of COVID-19 infection by …

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of ...

Cancer cells eat themselves to survive

It is the membrane of cancer cells that is at the focus of the new research now showing a completely new way in which cancer cells can repair the damage that can otherwis...

U.S. FDA grants Priority Review for the Biologics …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) granted Priority Review designation for the Biologics Li...

Collaboration between AbbVie, Biogen and Pfizer cr…

The access to the world's largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequenc...

Artificial intelligence could be new blueprint for…

Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses...

Anti-tumor agent from the intestine

It is believed to be involved in the development of chronic inflammatory intestinal diseases, to trigger diabetes, to be responsible for obesity, even neurological diseas...